The effect of protein binding on ibuprofen adsorption to activated carbons

Carbon

Volumn 42, Issue 3, 2004, Pages 565-571

  Melillo, M ^a   Phillips, G J ^a   Davies, J G ^a   Lloyd, A W ^a   Tennison, S R ^b   Kozynchenko, O P ^b   Mikhalovsky, S V ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b MAST Carbon Ltd   (United Kingdom)

Author keywords

Activated carbon; Adsorption; Blood purification; Ibuprofen

Indexed keywords

ADSORBENTS; ADSORPTION; BLOOD; DRUG PRODUCTS; FLUORESCENCE; MICROPOROUS MATERIALS; POLYMERS; PORE SIZE; PROTEINS; TOXICITY;

BLOOD PURIFICATION; IBUPROFEN;

ACTIVATED CARBON;

EID: 1042277370     PISSN: 00086223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbon.2003.12.064     Document Type: Article

References (24)

1. Cooney D.O. Activated charcoal in medical applications. 1995;Marcel Dekker, New York.
2. Flanagan R.J. Guidelines for the interpretation of analytical toxicology results and unit measurement conversion. Ann. Clin. Biochem. 35:1998;261-267.
3. Halpern S.M., Fitzpatrick R., Volans G.N. Ibuprofen toxicity. A review of adverse reactions and overdoses. Adverse Drug React. Toxicol. Rev. 12(2):1993;107-128.
4. Le H.T., Bosse G.M., Tsai Y. Ibuprofen overdoses complicated by renal failure, adult respiratory distress syndrome, and metabolic acidosis. J. Toxicol. Clin. Toxicol. 32(3):1994;315-320.
5. Seifert S.A., Bronstein A.C., McGuire T. Massive ibuprofen ingestion with survival. Clin. Toxicol. 38(1):2000;55-57.
6. McDonald G.A., Du Bose T.D. Jr., Molony D.A., Verani R. Nephrotoxicity of non-steroidal anti-inflammatory drugs. Lancet North Am. Ed. 44(8921):1994;515-519.
7. Levy H., Dasgupta A., Lin A., Blackwell W., Mosley A., Okarma T. Adsorption of charged non-albumin bound drugs by amorphous silica. J. Toxicol. Clin. Toxicol. 33(5):1995;457-463.
8. Gulyassy P.F., Depner T.A. Impaired binding of drugs and endogenous ligand in renal disease. Am. J. Kidney Dis. 2(6):1983;578-601.
9. Routledge P.A. The plasma protein binding of basic drugs. Br. J. Pharmacol. 22:1986;99-106.
10. Boehm H.P. Some aspects of the surface chemistry of carbon blacks and other carbons. Carbon. 32:1994;759-769.
11. Mikhalovsky S.V. Microparticles for hemoperfusion and extracorporeal therapy. Arshady R. Microspheres, microcapsules and liposomes. Medical & biotechnology applications. The MML series. vol. 2:1999;133-169 Citus Books, London.
12. Tyrode M.V. The mode of action of some purgative salts. Arch. Int. Pharmacodyn. 17:1910;205-209.
13. Terzyk A.P., Rychlicki G. The influence of activated carbon surface chemical composition on the adsorption of acetaminophen (paracetamol) in vitro: the temperature dependence of adsorption at the neutral pH. Coll. Surf. A: Physicochem. Eng. Aspects. 163(2-3):2000;135-150.
14. Khan A.R., Ataullah R., Al Haddad A. Equilibrium adsorption studies of some aromatic pollutants from dilute aqueous solutions on activated carbon at different temperatures. J. Colloid Interface Sci. 194(1):1997;154-165.
15. Epps D.E., Raub T.J., Kezdy F.J. A general, wide-range spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin. Anal. Biochem. 227(2):1995;342-350.
16. Epps D.E., Raub T.J., Caiolfa V., Chiari A., Zamai M. Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic tryptophan fluorescence of protein. J. Pharm. Pharmacol. 51:1999;41-48.
17. Parikh H.H., McElwain K., Balasubramanian V., Leung W., Wong D., Morris M.E., et al. A rapid spectrofluorometric technique for determining drug-serum protein binding suitable for high-throughput screening. Pharm. Res. 17(5):2000;632-637.
18. Denti E., Walker J.M. Activated carbon: properties, selection and evaluation. Carmelo G. Sorbents and their clinical applications. 1980;101-115 Academic Press, London.
19. Ronco C., Ghezzi P.M., Hoenich N.A., Delfino P. Membranes and filters for hemodialysis. Database 2001. 2001;Karger, Basel.
20. Kiselev M.A., Gryzunov Iu.A., Dobretsov G.E., Komarova M.N. Size of human serum albumin molecule in solution. Biophysics (Biofizika). 46(3):2001;423-427. (in Russian).
21. Freer A.A. Structure of (S)-(+)-ibuprofen. Acta Crystallogr. C. 49:1993;1378-1380.
22. Shankland N., Wilson C.C., Florence A.J., Cox P.J. Refinement of ibuprofen at 100 K by single-crystal pulsed neutron diffraction. Acta Crystallogr. C. 53:1997;951-954.
23. Hage D.S., Noctor T.A., Wainer I.W. Characterization of the protein binding of chiral drugs by high-performance affinity chromatography. Interaction of R- and S-ibuprofen with human serum albumin. J. Chromatogr. A. 693:1995;23-32.
24. Epps D.E., Raub T.J., Kezdy F.J. A general, wide range spectrofluorometric method for measuring the site-specific affinities of drugs towards human serum albumin. Anal. Biochem. 227:1995;342-350.